about
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, ...
Read More
0.84
0.00
(0.00%)
154.1K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
FibroBiologics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..